Propanc Biopharma Inc

Propanc Biopharma’s stock has experienced a dramatic rollercoaster ride, plummeting from a 52-week high of $222 to a low of $1.25, amidst concerns over the company’s financial health and the high-risk, high-reward nature of its biotech endeavors.